Tongde Capital is an investment firm that engaged in investment management and consulting.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jan 4, 2022
Bichen Pharmaceutical
|
Series B | $30M | Biopharma | — |
|
Jul 1, 2017
|
Angel | ¥10M | Children | Yes |
|
Jun 26, 2015
|
Post-IPO Equity | ¥76M | Manufacturing | — |
Tongde Capital has had 1 exits. Tongde Capital most notable exits include Hengda Gufen
| Date | Company Name | Exit Type | Industry | |
|---|---|---|---|---|
| Jan 15, 2015 | Hengda Gufen | IPO | Manufacturing | Detail |